40 CFR Part 799, Subpart H - Health Effects Test Guidelines
prev | next
- § 799.9110 TSCA acute oral toxicity.
- § 799.9120 TSCA acute dermal toxicity.
- § 799.9130 TSCA acute inhalation toxicity.
- § 799.9135 TSCA acute inhalation toxicity with histopathology.
- § 799.9305 TSCA Repeated dose 28-day oral toxicity study in rodents.
- § 799.9310 TSCA 90-day oral toxicity in rodents.
- § 799.9325 TSCA 90-day dermal toxicity.
- § 799.9346 TSCA 90-day inhalation toxicity.
- § 799.9355 TSCA reproduction/developmental toxicity screening test.
- § 799.9365 TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test.
- § 799.9370 TSCA prenatal developmental toxicity.
- § 799.9380 TSCA reproduction and fertility effects.
- § 799.9410 TSCA chronic toxicity.
- § 799.9420 TSCA carcinogenicity.
- § 799.9430 TSCA combined chronic toxicity/carcinogenicity.
- § 799.9510 TSCA bacterial reverse mutation test.
- § 799.9530 TSCA in vitro mammalian cell gene mutation test.
- § 799.9537 TSCA in vitro mammalian chromosome aberration test.
- § 799.9538 TSCA mammalian bone marrow chromosomal aberration test.
- § 799.9539 TSCA mammalian erythrocyte micronucleus test.
- § 799.9620 TSCA neurotoxicity screening battery.
- § 799.9630 TSCA developmental neurotoxicity.
- § 799.9748 TSCA metabolism and pharmacokinetics
- § 799.9780 TSCA immunotoxicity.
Source:
62 FR 43824, Aug. 15, 1997, unless otherwise noted.